Mode of Death in Heart Failure With Preserved Ejection Fraction
- PMID: 28153111
- DOI: 10.1016/j.jacc.2016.10.078
Mode of Death in Heart Failure With Preserved Ejection Fraction
Abstract
Little is known about specific modes of death in patients with heart failure with preserved ejection fraction (HFpEF). Herein, the authors critically appraise the current state of data and offer potential future directions. They conducted a systematic review of 1,608 published HFpEF papers from January 1, 1985, to December 31, 2015, which yielded 8 randomized clinical trials and 24 epidemiological studies with mode-of-death data. Noncardiovascular modes of death represent an important competing risk in HFpEF. Although sudden death accounted for ∼25% to 30% of deaths in trials, its definition is nonspecific; it is unclear what proportion represents arrhythmic deaths. Moving forward, reporting and definitions of modes of death must be standardized and tailored to the HFpEF population. Broad-scale systematic autopsies and long-term rhythm monitoring may clarify the underlying pathology and mechanisms driving mortal events. There is an unmet need for a longitudinal multicenter, global registry of patients with HFpEF to map its natural history.
Keywords: epidemiology; mortality; outcomes.
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Similar articles
-
How do patients with heart failure with preserved ejection fraction die?Eur J Heart Fail. 2013 Jun;15(6):604-13. doi: 10.1093/eurjhf/hft062. Epub 2013 Apr 21. Eur J Heart Fail. 2013. PMID: 23610137 Review.
-
Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial.Circulation. 2010 Mar 30;121(12):1393-405. doi: 10.1161/CIRCULATIONAHA.109.909614. Epub 2010 Mar 15. Circulation. 2010. PMID: 20231531 Clinical Trial.
-
A prediction model for sudden cardiac death in patients with heart failure and preserved ejection fraction.Eur J Heart Fail. 2014 Nov;16(11):1175-82. doi: 10.1002/ejhf.172. Epub 2014 Oct 10. Eur J Heart Fail. 2014. PMID: 25302657
-
Sudden cardiac death in heart failure with preserved ejection fraction: a target for therapy?Heart Fail Rev. 2016 Jul;21(4):455-62. doi: 10.1007/s10741-016-9525-z. Heart Fail Rev. 2016. PMID: 26762335 Review.
-
The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).JACC Heart Fail. 2015 Jun;3(6):429-441. doi: 10.1016/j.jchf.2014.12.017. Epub 2015 May 14. JACC Heart Fail. 2015. PMID: 25982110
Cited by
-
Cancer and Heart Failure: Dangerous Liaisons.J Cardiovasc Dev Dis. 2024 Aug 27;11(9):263. doi: 10.3390/jcdd11090263. J Cardiovasc Dev Dis. 2024. PMID: 39330321 Free PMC article. Review.
-
Heart failure with preserved ejection fraction.Nat Rev Dis Primers. 2024 Aug 14;10(1):55. doi: 10.1038/s41572-024-00540-y. Nat Rev Dis Primers. 2024. PMID: 39143132 Review.
-
Sudden Cardisac Death in Patients With Advanced Heart Failure and Preserved Ejection Fraction.Circ Arrhythm Electrophysiol. 2024 Jul;17(7):e012724. doi: 10.1161/CIRCEP.123.012724. Epub 2024 Jun 5. Circ Arrhythm Electrophysiol. 2024. PMID: 38836347 No abstract available.
-
The impact of atrial fibrillation on clinical outcomes in heart failure with mid-range and preserved ejection fraction patients.Heart Rhythm. 2024 Nov;21(11):2110-2117. doi: 10.1016/j.hrthm.2024.05.039. Epub 2024 May 24. Heart Rhythm. 2024. PMID: 38797306 Clinical Trial.
-
Heart failure with preserved ejection fraction: implications for anaesthesia.BJA Educ. 2024 May;24(5):155-163. doi: 10.1016/j.bjae.2024.02.003. Epub 2024 Mar 6. BJA Educ. 2024. PMID: 38646450 Review. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
